Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Accenture delivered better-than-expected results for the second quarter of fiscal 2025, but the stock took a steep hit as investor concerns mounted over potential fallout from U.S. federal cost-cutting initiatives.</li><li>The consulting giant posted earnings of $2.82 per share, just above the analyst consensus of $2.81, and reported revenue of $16.7 billion, surpassing expectations of $16.6 billion and marking a 5% year-over-year increase.</li><li>However, despite this beat, the company’s shares plunged 9.4% to $292.72, logging their worst single-day performance since June 2013 and becoming the S&P 500’s worst performer on the day.</li></ul>

Accenture delivered better-than-expected results for the second quarter of fiscal 2025, but the stock took a steep hit as investor concerns mounted over potential fallout from U.S. federal cost-cutting initiatives.The consulting giant posted earnings of $2.82 per share, just above the analyst consensus of $2.81, and reported revenue of $16.7 billion, surpassing expectations of $16.6 billion and marking a 5% year-over-year increase.However, despite this beat, the company’s shares plunged 9.4% to $292.72, logging their worst single-day performance since June 2013 and becoming the S&P 500’s worst performer on the day.

Accenture Just Crushed Earnings — But DOGE Could Be Its Worst Nightmare Yet!

Accenture Plc Cl A

Accenture Just Crushed Earnings — But DOGE Could Be Its Worst Nightmare Yet!